The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer.
Novel dioxazine- and oxdiazine-substituted arylamides of the formula (I)
in which A
1
, A
2
, R
1
, R
2
, R
3
, R
4
and R
5
are as defined in the description,
a plurality of processes for preparing these compounds and their use for controlling pests, and also novel intermediates and processes for their preparation.
Novel dioxazine- and oxdiazine-substituted arylamides of the formula (I)
in which A
1
, A
2
, R
1
, R
2
, R
3
, R
4
and R
5
are as defined in the description,
a plurality of processes for preparing these compounds and their use for controlling pests, and also novel intermediates and processes for their preparation.
The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer.